Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer (Q38359636)

2 September 2017

title

Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer (English)

1 reference

lip and oral cavity carcinoma

2 September 2017

0 references

1 reference

1 reference

Hironari Dehari

1

1 reference

2 September 2017

Yoshinori Ito

2

1 reference

2 September 2017

Takafumi Nakamura

3

1 reference

2 September 2017

Masayoshi Kobune

4

1 reference

2 September 2017

Katsunori Sasaki

5

1 reference

2 September 2017

Noriyuki Yonekura

6

1 reference

2 September 2017

Geniku Kohama

7

1 reference

2 September 2017

Hirofumi Hamada

8

1 reference

2 September 2017

publication date

1 January 2003

1 reference

2 September 2017

1 reference

2 September 2017

volume

10

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

75-85

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700529

2 September 2017

exact match

0 references

cites work

Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Optimizing suicide gene therapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Sensitivity and reproducibility in adenoviral infectious titer determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

RGD and other recognition sequences for integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Isolation and analysis of cDNA and genomic clones of fibronectin and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Integrins and oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

Major complications of radiotherapy in cancer of the oral cavity and oropharynx. A 10 year retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

Involvement of cellular adhesion sequences in the attachment of adenovirus to the HeLa cell surface

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700529

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700529

1 reference

2 September 2017

1 reference